Khan, A.A.; Alanazi, A.M.; Alsaif, N.; Algrain, N.; Wani, T.A.; Bhat, M.A.
Enhanced Efficacy of Thiosemicarbazone Derivative-Encapsulated Fibrin Liposomes against Candidiasis in Murine Model. Pharmaceutics 2021, 13, 333.
https://doi.org/10.3390/pharmaceutics13030333
AMA Style
Khan AA, Alanazi AM, Alsaif N, Algrain N, Wani TA, Bhat MA.
Enhanced Efficacy of Thiosemicarbazone Derivative-Encapsulated Fibrin Liposomes against Candidiasis in Murine Model. Pharmaceutics. 2021; 13(3):333.
https://doi.org/10.3390/pharmaceutics13030333
Chicago/Turabian Style
Khan, Azmat Ali, Amer M. Alanazi, Nawaf Alsaif, Nasser Algrain, Tanveer Ahmad Wani, and Mashooq Ahmad Bhat.
2021. "Enhanced Efficacy of Thiosemicarbazone Derivative-Encapsulated Fibrin Liposomes against Candidiasis in Murine Model" Pharmaceutics 13, no. 3: 333.
https://doi.org/10.3390/pharmaceutics13030333
APA Style
Khan, A. A., Alanazi, A. M., Alsaif, N., Algrain, N., Wani, T. A., & Bhat, M. A.
(2021). Enhanced Efficacy of Thiosemicarbazone Derivative-Encapsulated Fibrin Liposomes against Candidiasis in Murine Model. Pharmaceutics, 13(3), 333.
https://doi.org/10.3390/pharmaceutics13030333